M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Pfizer to buy portfolio of marketed vaccines for USD635m
Science company Pfizer (NYSE:PFE) reported on Wednesday the launch of a definitive agreement to acquire a portfolio of marketed vaccines, NeisVac-C and FSME-IMMUN/TicoVac, from Baxter International for USD635m.
Pursuant to the agreement, Pfizer will acquire a portion of Baxter's facility...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives